The pregnancy outcomes analysis of 19948 cycles of women who treated by different protocols of artificial insemination used donor sperm
Key Laboratory of Male Reproduction and Genetics of National Health and Family Planning Commission, Family Planning Science and Technology Research Institute Reproductive Center of Guangdong Province, Guangzhou, Guangdong Province, 510600
摘要目的:探讨不同治疗方案对供精人工授精(AID)妊娠结局的影响。方法: 回顾性分析2011年1月—2017年12月在本院接受AID治疗的19 948个周期,其中自然周期14390个,促排卵周期5558个。促排卵周期中克罗米芬(CC)、他莫昔芬和尿促性腺激素(hMG)促排卵周期分别为812、1229和491个,比较不同治疗方案的临床效果。 结果:自然周期组临床妊娠率高于他莫昔芬和hMG组 (OR 1.414,95% CI 1.254-1.595;OR 1.221,95% CI 1.073-1.388);CC组的临床妊娠率高于他莫昔芬组 (OR=1.253,95% CI 1.062-1.478)。自然周期组的活产率高于CC、他莫昔芬和hMG组 (OR 1.175,95% CI1.025-1.346;OR 1.432,95% CI1.259-1.628;OR 1.211,95% CI 1.057-1.388);CC组的活产率高于他莫昔芬组 (OR 1.219,95% CI 1.021-1.455)。CC和hMG组的多胎率明显高于自然周期组(OR 7.828,95% CI 3.976-15.413;OR 13.941,95% CI 7.617-25.518);CC和hMG组的多胎率高于他莫昔芬组 (OR 21.264,95% CI2.829-159.828;OR 37.871,95% CI 5.149-278.558)。结论:在AID中,排卵功能正常女性,应进行自然周期的AID手术;在促排卵周期,应首选CC促排卵方案。
张清健 宋革 钟小英 姜荣华 刘晓玲 郑炜炜 祝晓丽 黎敏茹 詹泽虎 蔡晓林 陈翘. 19948个供精人工授精AID周期不同治疗方案的妊娠结局分析[J]. 中国计划生育学杂志, 2019, 27(10): 1294-.
ZHANG Qingjian, SONG Ge, ZHONG Xiaoying, JIANG Ronghua, LIU Xiaoling, ZHENG Weiwei, ZHU Xiaoli, LI Minru, ZHAN Zehu, CAI Xiaolin, CHEN Qiao. The pregnancy outcomes analysis of 19948 cycles of women who treated by different protocols of artificial insemination used donor sperm. 中国计划生育学杂志, 2019, 27(10): 1294-.